In this issue:
Daily aspirin lowers cancer risk
Colonoscopy may halve CRC mortality
Management of malignant colonic polyps
Characterising chemoresistance in CRC
Blood-based SEPT9 testing: high predictive value
CAPIRI-bevacizumab: toxicity in mCRC
Cetuximab outcomes similar across age groups
Adding bevacizumab to chemotherapy improves outcomes
Peritoneal carcinomatosis CRC: limited options
Chemotherapy options in advanced CRC
Please login below to download this issue (PDF)